Infinity Equity Management Co., Ltd. (Infinity Capital) is an affiliate of Infinity Group, a leading investment management company from Israel. Infinity Capital operates the core businesses in Greater China, which mainly involves a domestic RMB fund and cross-border M&A. Infinity Capital has offices in 12 cities across China, covering the five major business areas, North China, East China, South China, Southwest, Hong Kong as well as overseas. With the advantage of having resources in Israel, we insist on introducing cross-border capital investment in innovative technology, and we are committed to building important ties and bridges of cooperation in science, technology and innovation between China and Israel.
At present, the investment fund of Infinity in China has nearly 5 billion RMB invested in TMT (science and technology, media, communications), health and life sciences, energy conservation and environmental protection, precision manufacturing and new materials and other areas of the key layout. In the last two years alone, Infinity Capital has had four successful listings: Vincent Medical (HK01612), AsymChem (002821), Huati Technology (603679), Liancheng Precision (002921). Golden Point Gardens, Hongtu Separator, IOPtima has been acquired by Meishang Ecology (300495). Jinguan Electrical (300510), Kanghong Pharmaceutical (002773) respectively which has achieved good results. Additionally, at present, a number of portfolio companies are preparing to IPO.
Infinity Capital maintains close cooperation with well-known outstanding venture capital companies and listed companies, adheres to the prudent and professional investment philosophy, and is constantly helping the investment companies to continue to grow, creating long-term and generous returns for shareholders and partners under low risk.
At the same time, Infinity Capital makes full use of its channel and resource advantages in Israel. Since 2016, it has organized four China-Israel Technology Innovation Investment Summits, which have made positive contributions to promoting innovation and pragmatic cooperation between China and Israel. In particular, the third and fourth Summit congresses jointly hosted by Huafa Group in Zhuhai, received strong support from the State, Guangdong Province and Zhuhai City, and successfully attracted more than 5000 innovative enterprises from China and Israel, and more than 10,000 guests attended the Summit. The total amount of cooperation reached exceeded 3 billion USD, which has become the largest scientific and technological innovation exchange activity between China and Israel since the establishment of diplomatic relations, and has injected new vitality into the promotion of the "Belt and Road Initiative" and cooperation in scientific and technological innovation between China and Israel.
In the future, Infinity Capital will continue to play its role as a bridge and link between China and Israel, explore high-quality innovation resources from a global perspective, and help Chinese enterprises to deeply integrate into the global scientific and technological innovation network.